unjha-formulations-ltd

Unjha Formulations Ltd Financials
Company Logo

Unjha Formulations Ltd Financial Statement

Unjha Formulations Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue3.81
Operating Expense3.89
Net Profit-0.11
Net Profit Margin-2.89
Earning Per Share-0.02
EBIDTA-0.09
Effective Tax RateTBA

Unjha Formulations Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual18.50
Operating Expenses Annual17.92
Operating Profit Annual0.59
Interest Annual0.05
Depreciation0.08
Net Profit Annual0.28
Tax Annual0.17

Unjha Formulations Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.01
Cash Flow from Operations1.03
Cash Flow from Investing-0.11
Cash Flow from Financing-0.05
Cash Flow at the End0.87

Unjha Formulations Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)3.14
PBIT Margin (%)2.70
PBT Margin (%)-51.35
Net PROFIT Margin (%)1.51
Return On Networth / Equity (%)6
Return On Networth /Employed (%)10.71
Return On Assets (%)10.79
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)7.13

Unjha Formulations Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1.12
Total Current Assets Annual3.81
Non Current Assets Annual1.12
Total Shareholders Funds Annual2.73
Total Assets Annual4.93

Unjha Formulations Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 12, 2024, Unjha Formulations Ltd has a market capitalization of 8.47 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Unjha Formulations Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Unjha Formulations Ltd recorded a total revenue of approximately 18.50 Cr marking a significant milestone in the company's financial performance.
Unjha Formulations Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..
Unjha Formulations Ltd's current PE ratio is 30.25.
Unjha Formulations Ltd's ROCE averaged 18.1% from the FY ending March 2022 to 2024, with a median of 18.6%. It peaked at 19.9% in March 2022, reflecting strong capital efficiency over the period..
Unjha Formulations Ltd's latest EBIT is Rs. 0.51 Cr, surpassing the average EBIT of Rs. 0.44 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions